Clinical Trial Update: Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE) [Phase 3]

View source ↗

Summary

Phase III trial comparing dabigatran etexilate with warfarin for six months of treatment in acute symptomatic venous thromboembolism has completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Pradaxa (dabigatran etexilate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Thromboembolism | Phase 3 | Status: COMPLETED | Results posted: 2012-06-14